US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
T2 Biosystems Inc (TTOO)
T2 Biosystems Inc (TTOO) ニュース

TTOO

T2 Biosystems (TTOO)

T2 Biosystems Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TTOO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/24	22 : 00	GlobeNewswire Inc.	T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	NASDAQ:TTOO	T2 Biosystems Inc
2024/04/12	05 : 05	GlobeNewswire Inc.	T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	NASDAQ:TTOO	T2 Biosystems Inc
2024/03/28	22 : 00	GlobeNewswire Inc.	T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	NASDAQ:TTOO	T2 Biosystems Inc
2024/03/20	20 : 30	GlobeNewswire Inc.	T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	NASDAQ:TTOO	T2 Biosystems Inc
2024/03/19	22 : 00	GlobeNewswire Inc.	T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	NASDAQ:TTOO	T2 Biosystems Inc
2024/03/18	22 : 00	GlobeNewswire Inc.	T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	NASDAQ:TTOO	T2 Biosystems Inc
2024/03/12	22 : 00	GlobeNewswire Inc.	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	NASDAQ:TTOO	T2 Biosystems Inc
2024/03/05	06 : 34	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/28	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/28	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/28	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/21	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/21	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/21	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/21	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/17	07 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/17	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/16	06 : 49	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/16	06 : 47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/16	06 : 06	GlobeNewswire Inc.	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/16	06 : 04	GlobeNewswire Inc.	T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/16	06 : 02	GlobeNewswire Inc.	T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/14	10 : 15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/12	23 : 00	GlobeNewswire Inc.	T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel	NASDAQ:TTOO	T2 Biosystems Inc
2024/02/08	06 : 05	GlobeNewswire Inc.	T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024	NASDAQ:TTOO	T2 Biosystems Inc
2024/01/18	23 : 00	GlobeNewswire Inc.	T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients	NASDAQ:TTOO	T2 Biosystems Inc
2024/01/06	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TTOO	T2 Biosystems Inc
2024/01/04	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc
2024/01/03	23 : 00	GlobeNewswire Inc.	T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing	NASDAQ:TTOO	T2 Biosystems Inc
2023/11/29	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTOO	T2 Biosystems Inc

Showing the most relevant articles for your search:NASDAQ:TTOO

1 2 3 4 5 6 7 8 9 10 次へ >>

American Express

Energy Select Sector SPDR

Financial Select Sector

Bank of America

Invesco QQQ Trust Series 1

US Dollar vs Sterling

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約